DOI 10.1016/j.jacl.2026.07.022
Physiological vs risk-relevant lipid remodeling across the menopausal transition: FMP-anchored trajectories, male benchmarking, LDLR genetics, risk calibration, and incident MACE in 273,036 UK Biobank women.
Аннотация
BACKGROUND
Cardiovascular risk factors accelerate around the final menstrual period (FMP), yet no operational method separates expected physiology from risk-relevant divergence, and age-weighted calculators may under-recognise midlife women.
OBJECTIVE
To define the expected physiological envelope of menopausal lipid remodelling, distinguish it from risk-relevant divergence, and test whether sex-neutral guideline cutpoints correctly represent female absolute risk against incident major adverse cardiovascular events (MACE).
METHODS
We analysed 273,036 UK Biobank women (63,939 premenopausal; 165,276 postmenopausal; status self-reported) with nuclear magnetic resonance metabolomics (n=222,487), cardiac magnetic resonance imaging (n=42,033), an age-matched male reference (n=228,900) and incident MACE follow-up (224,256 women, 16,961 events; Cox subcohort 151,812, 11,237 events). Analyses integrated FMP-anchored trajectories, male-matched classification, treatment-adjusted change, oestradiol mediation, Mendelian randomisation (MR), low-density lipoprotein receptor (LDLR) stratification and cutpoint calibration.
RESULTS
Postmenopausal women had higher LDL-C (+15.3%), ApoB (+13.5%), non-HDL-C (+16.8%) and triglycerides (+29.9%); treatment adjustment raised LDL-C and ApoB to +19.8% and +17.5%. Male-matching classified ApoB, LDL-C and remnants as menopause-linked. LDL-C and ApoB accelerated around the FMP (breakpoints 4.32 and 4.48 years); oestradiol mediated 61.5% of the LDL-C difference. MR supported LDL-C causality (HR 1.196 [1.018-1.374]) with a null menopause interaction; LDLR carriers started higher but did not rise faster (+11.5% vs +15.3%). ApoB tracked ischaemic heart disease (HR 1.125 [1.104-1.146]) but not heart failure. At age 58, ApoB ≥1.2 g/L conferred 10.88% versus 4.34% 10-year MACE risk in men versus postmenopausal women; sex-neutral models over-predicted women.
CONCLUSION
Menopausal lipid remodeling comprises an expected physiological envelope and a risk-relevant, ApoB-rich divergence predicting ischaemic heart disease. Because static sex-neutral cutpoints misestimate female risk, transition-era prevention needs sex-specific absolute-risk interpretation; monitoring bands are hypothesis-generating, requiring prospective validation.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.